| ASSET | QUARTER | % RETURN |
|---|---|---|
Future Fintech (FTFT) | Q1 2004 | 779,905.04% |
Oragenics (OGEN) | Q1 2004 | 1,856.18% |
Theriva Biologics (TOVX) | Q1 2004 | 900% |
NeoGenomics (NEO) | Q1 2004 | 800.4% |
ACCESS Newswire (ACCS) | Q1 2004 | 700% |
QXO (QXO) | Q1 2004 | 550% |
Inuvo (INUV) | Q1 2004 | 432.61% |
Ammo (POWW) | Q1 2004 | 400% |
Inseego (INSG) | Q1 2004 | 257.74% |
Widepoint C (WYY) | Q1 2004 | 253.85% |
Repro Med Systems (KRMD) | Q1 2004 | 237.5% |
Lifeway Foods (LWAY) | Q1 2004 | 227.67% |
Delcath Systems (DCTH) | Q1 2004 | 204.21% |
Oramed Pharmaceuticals (ORMP) | Q1 2004 | 201.56% |
CervoMed (CRVO) | Q1 2004 | 200% |
Paysign (PAYS) | Q1 2004 | 200% |
Astrotech (ASTC) | Q1 2004 | 197.95% |
Usio (USIO) | Q1 2004 | 186.67% |
Axon Enterprise (AXON) | Q1 2004 | 183.47% |
Senstar Technologies (SNT) | Q1 2004 | 181.26% |
Air Industries (AIRI) | Q1 2004 | 176.95% |
Euro Tech (CLWT) | Q1 2004 | 149.74% |
Savara (SVRA) | Q1 2004 | 141.38% |
Sono-Tek (SOTK) | Q1 2004 | 137.25% |
Arrowhead Pharmaceuticals (ARWR) | Q1 2004 | 130.77% |